| Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32 | Sarah de Crescenzo | 11/05/19 | San Diego |
| Xconomy Boston’s Top 10 Stories from Q3 2013: Editor’s Picks | Gregory T. Huang | 09/30/13 | Boston |
| New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures | Erin Kutz | 04/09/12 | Boston |
| See You Today at New England’s Emerging Biotech Stars***SOLD OUT*** | Arlene Weintraub | 04/04/12 | Boston |
| Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation | Arlene Weintraub | 03/29/12 | Boston |
| Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum | Arlene Weintraub | 03/15/12 | Boston |
| New England’s Emerging Biotech Stars: The Agenda | Arlene Weintraub | 03/08/12 | Boston |
| New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event | Arlene Weintraub | 01/26/12 | Boston |
| 2009’s Top 10 Private Equity Deals in Massachusetts: The List | Ryan McBride | 01/25/10 | Boston |
| Aileron Develops New Class of Drugs To Go Where None Could Before | Luke Timmerman | 11/07/08 | Boston |
